Tower Research Capital LLC (TRC) - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 54 filers reported holding CIDARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,615
-80.3%
2,776
-76.4%
0.00%
Q2 2023$13,28011,752
+5776.0%
0.00%
Q1 2023$0
-100.0%
200
-99.1%
0.00%
-100.0%
Q4 2022$16
-99.8%
21,436
+67.2%
0.00%
Q3 2022$8,000
-27.3%
12,823
-42.3%
0.00%
Q2 2022$11,000
+57.1%
22,227
+158.4%
0.00%
Q1 2022$7,000
-53.3%
8,601
-27.8%
0.00%
Q4 2021$15,000
+36.4%
11,905
+143.9%
0.00%
Q3 2021$11,000
-60.7%
4,881
-54.0%
0.00%
Q1 2021$28,000
+47.4%
10,603
+11.8%
0.00%
-100.0%
Q4 2020$19,000
-79.6%
9,482
-71.1%
0.00%0.0%
Q3 2020$93,000
-8.8%
32,790
+19.0%
0.00%
-75.0%
Q2 2020$102,000
+10100.0%
27,556
+4000.6%
0.00%
Q3 2019$1,000672
+761.5%
0.00%
Q2 2019$0
-100.0%
78
-99.4%
0.00%
-100.0%
Q1 2019$34,000
+1033.3%
12,813
+861.9%
0.00%
Q4 2018$3,000
-95.6%
1,332
-91.3%
0.00%
-100.0%
Q3 2018$68,000
+161.5%
15,318
+212.2%
0.01%
+400.0%
Q2 2018$26,000
+85.7%
4,907
+45.9%
0.00%0.0%
Q1 2018$14,000
+180.0%
3,364
+392.5%
0.00%0.0%
Q4 2017$5,000
+150.0%
683
+197.0%
0.00%
Q3 2017$2,000
-50.0%
230
-56.5%
0.00%
Q2 2017$4,000
+100.0%
529
+149.5%
0.00%
Q3 2016$2,000
-33.3%
212
-22.1%
0.00%
Q2 2016$3,000
+200.0%
272
+444.0%
0.00%
Q1 2016$1,000
-91.7%
50
-93.0%
0.00%
-100.0%
Q4 2015$12,000
+300.0%
716
+161.3%
0.00%
Q3 2015$3,000
+200.0%
274
+364.4%
0.00%
Q2 2015$1,000590.00%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders